Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Mammalian pigmentation is regulated by a distinct cAMP-dependent mechanism that controls melanosome pH.

Zhou D, Ota K, Nardin C, Feldman M, Widman A, Wind O, Simon A, Reilly M, Levin LR, Buck J, Wakamatsu K, Ito S, Zippin JH.

Sci Signal. 2018 Nov 6;11(555). pii: eaau7987. doi: 10.1126/scisignal.aau7987.

PMID:
30401788
2.

Ultraviolet radiation accelerates NRas-mutant melanomagenesis: A cooperative effect blocked by sunscreen.

Hennessey RC, Holderbaum AM, Bonilla A, Delaney C, Gillahan JE, Tober KL, Oberyszyn TM, Zippin JH, Burd CE.

Pigment Cell Melanoma Res. 2017 Sep;30(5):477-487. doi: 10.1111/pcmr.12601. Epub 2017 Jul 4.

PMID:
28544727
3.

Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma.

Trousil S, Chen S, Mu C, Shaw FM, Yao Z, Ran Y, Shakuntala T, Merghoub T, Manstein D, Rosen N, Cantley LC, Zippin JH, Zheng B.

J Invest Dermatol. 2017 May;137(5):1135-1143. doi: 10.1016/j.jid.2017.01.013. Epub 2017 Jan 28.

4.

Stoma care products represent a common and previously underreported source of peristomal contact dermatitis.

Cressey BD, Belum VR, Scheinman P, Silvestri D, McEntee N, Livingston V, Lacouture ME, Zippin JH.

Contact Dermatitis. 2017 Jan;76(1):27-33. doi: 10.1111/cod.12678. Epub 2016 Aug 31.

5.

Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase.

Ramos-Espiritu L, Kleinboelting S, Navarrete FA, Alvau A, Visconti PE, Valsecchi F, Starkov A, Manfredi G, Buck H, Adura C, Zippin JH, van den Heuvel J, Glickman JF, Steegborn C, Levin LR, Buck J.

Nat Chem Biol. 2016 Oct;12(10):838-44. doi: 10.1038/nchembio.2151. Epub 2016 Aug 22.

6.

The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein.

Ramos-Espiritu L, Diaz A, Nardin C, Saviola AJ, Shaw F, Plitt T, Yang X, Wolchok J, Pirog EC, Desman G, Sboner A, Zhang T, Xiang J, Merghoub T, Levin LR, Buck J, Zippin JH.

Oncotarget. 2016 Jul 19;7(29):45597-45607. doi: 10.18632/oncotarget.10056.

7.

Investigation of cAMP microdomains as a path to novel cancer diagnostics.

Desman G, Waintraub C, Zippin JH.

Biochim Biophys Acta. 2014 Dec;1842(12 Pt B):2636-45. doi: 10.1016/j.bbadis.2014.08.016. Epub 2014 Sep 7. Review.

8.
9.

Allergic contact dermatitis to timolol: a report of 2 cases and review of the literature.

Chernoff KA, Zippin JH.

Dermatitis. 2014 Jan-Feb;25(1):41-2. doi: 10.1097/DER.0000000000000006. Review. No abstract available.

PMID:
24407055
10.

Allergic contact dermatitis to cosmetics.

Park ME, Zippin JH.

Dermatol Clin. 2014 Jan;32(1):1-11. doi: 10.1016/j.det.2013.09.006. Review.

PMID:
24267417
11.

CO2/HCO3(-)- and calcium-regulated soluble adenylyl cyclase as a physiological ATP sensor.

Zippin JH, Chen Y, Straub SG, Hess KC, Diaz A, Lee D, Tso P, Holz GG, Sharp GW, Levin LR, Buck J.

J Biol Chem. 2013 Nov 15;288(46):33283-91. doi: 10.1074/jbc.M113.510073. Epub 2013 Oct 7.

12.

Cutaneous Cryptococcoma in a Patient on TNF-α Inhibition.

Gomes RM, Cerio DR, Loghmanee C, McKinney J, Patel M, Miraglia J, Yousef-Bessler M, Zippin JH, Schuetz AN, Pinho PB.

J Clin Med. 2013 Nov 22;2(4):260-3. doi: 10.3390/jcm2040260.

13.

Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells.

Flacke JP, Flacke H, Appukuttan A, Palisaar RJ, Noldus J, Robinson BD, Reusch HP, Zippin JH, Ladilov Y.

J Biol Chem. 2013 Feb 1;288(5):3126-35. doi: 10.1074/jbc.M112.403279. Epub 2012 Dec 19.

14.
15.

Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions.

Magro CM, Crowson AN, Desman G, Zippin JH.

Arch Dermatol. 2012 Mar;148(3):335-44. doi: 10.1001/archdermatol.2011.338. Epub 2011 Nov 21.

16.

Current treatments for infantile hemangiomas.

Akhavan A, Zippin JH.

J Drugs Dermatol. 2010 Feb;9(2):176-80. Review. No abstract available.

PMID:
20214185
17.

Soluble adenylyl cyclase defines a nuclear cAMP microdomain in keratinocyte hyperproliferative skin diseases.

Zippin JH, Chadwick PA, Levin LR, Buck J, Magro CM.

J Invest Dermatol. 2010 May;130(5):1279-87. doi: 10.1038/jid.2009.440. Epub 2010 Feb 4.

18.

Cutaneous T-cell lymphoma: a review of current therapies and the future therapeutic implications of chemokine biology.

Momtaz P, Zippin JH.

J Drugs Dermatol. 2009 Dec;8(12):1142-9. Review. No abstract available.

PMID:
20027945
19.

Nanotechnology in cosmetics and sunscreens: an update.

Zippin JH, Friedman A.

J Drugs Dermatol. 2009 Oct;8(10):955-8. No abstract available.

PMID:
19852128
20.

Alpha-melanocyte stimulating hormone analogues: the perils and the promise.

Mazza JM, Zippin JH.

J Drugs Dermatol. 2009 Aug;8(8):772-6. Review. No abstract available.

PMID:
19663117

Supplemental Content

Loading ...
Support Center